Tag Archives: myl

Mylan, AbbVie News Shows Tax Inversion Boom Continues

The push for U.S. companies to move overseas kept investors busy Monday as Mylan agreed to buy part of Abbott Laboratories’ generic-drug business and relocate to the Netherlands. Mean while, Abbott’s former proprietary-drug unit AbbVie closed in on a deal for Anglo-Irish Shire Pharmaceuticals with its fifth offer. Abbott (ABT) will keep its branded generics business in emerging markets, but Mylan (MYL) will acquire the portion that operates in

Mylan Buying Abbott Generics Unit, Moving Abroad

The push for U.S. companies to move overseas kept investors busy Monday as Mylan (MYL) agreed to buy part of Abbott Laboratories’ (ABT) generic-drug business and relocate to the Netherlands, sending its stock up nearly 3% on the stock market. Meanwhile, Abbott’s former proprietary-drug unit AbbVie (ABBV) revised its bid for Britain’s Shire (SHPG) again after the latter finally came to the bargaining table. Abbott will hang on to its branded

Mylan Rejected In Bid To Acquire Sweden’s Meda

Generic-drug giant Mylan (MYL) on Friday lost out in a takeover bid for Swedish counterpart Meda, but its stock was still up more than 4% in midday trading on the stock market. Late Thursday, Britain’s Financial Times reported that Mylan and Meda were in talks. It didn’t say exactly what Mylan bid, but said it was a “significant premium” to Meda’s market cap of $4.5 billion. Meda is traded on the Stockholm exchange. Citi analyst Liav Abraham was